576
Views
85
CrossRef citations to date
0
Altmetric
Original Article

Efficacy of tranexamic acid in reducing blood loss after cesarean section

, MD, , , &
Pages 72-75 | Received 28 May 2008, Accepted 11 Jul 2008, Published online: 07 Jul 2009
 

Abstract

Aim. To assess the efficacy and safety of tranexamic acid in reducing blood loss at caesarian section (CS).

Method. A prospective randomised study conducted on 90 primiparas divided into two groups who underwent CS. The study group, 45 women, received tranexamic acid immediately before CS, whereas the control group, 45 women received placebo. Blood loss volume was measured from the end of CS to 2 h postpartum and compared between the two groups. Hemoglobin (Hb) and hematocrit (Hct) were tested 24 h after CS and compared between the two groups.

Results. Tranexamic acid significantly reduced the blood loss from the end of CS to 2 h postpartum; 28.02 ± 5.53 mL in the tranexamic group versus 37.12 ± 8.97 mL in the control group (p = 0.000). Hb 24 h after CS was significantly greater in tranexamic group than control group (12.57 ± 1.33 in the tranexamic group and 11.74 ± 1.14 in the control group, p = 0.002). No complications or side effects were reported in either group.

Conclusions. Tranexamic acid statistically reduces blood loss from end to 2 h after CS and its use was not associated with any side effects or complications. Consequently, tranexamic acid can be used safely and effectively to reduce bleeding resulting from CS.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.